← All Chinese sets, prices and the most valuable

Chinese CSM2cC

Chinese CSM2cC Card List: 34 cards (37 with variants), with prices

Chinese CSM2cC has 34 cards. A full set costs about $1,739 raw; 10 cards are worth $50+. The most valuable is Gardevoir & Sylveon GX #167 at $268 raw, $405 in PSA 10; 67% of its 17,559 PSA-graded cards are 10s.

Released: January 18, 2023
See the most valuable Chinese CSM2cC cards → PSA population report →
Total Cards
37
Total Value
$1753.90
Current market prices
Most Valuable
$268.50
Gardevoir & Sylveon GX #167
Market Activity
5,464
Total recent sales

Chinese CSM2cC Card List & Investment Insights

This complete Chinese CSM2cC card list provides up-to-date market values for all 37 cards in the set. Released on January 18, 2023, this set has a total current market value of $1753.90.

Top Chinese CSM2cC Cards by Value

The most valuable cards in the Chinese CSM2cC set include:

  • 1 Gardevoir & Sylveon GX #167
    $268.50 142 sales
  • 2 Umbreon & Darkrai GX #158
    $177.38 77 sales
  • 3 Togepi & Cleffa & Igglybuff GX #165
    $154.46 98 sales
  • 4 Moltres & Zapdos & Articuno GX #173
    $136.39 69 sales
  • 5 Snorlax And Eevee GX #171
    $107.88 111 sales
  • 6 Reshiram & Zekrom GX #169
    $98.76 108 sales
  • 7 Mega Sableye & Tyranitar GX #160
    $66.88 84 sales
  • 8 Erika's Hospitality #176
    $64.64 31 sales
  • 9 Moltres & Zapdos & Articuno GX #185
    $58.00 109 sales
  • 10 Umbreon & Darkrai GX #157
    $50.50 93 sales

Frequently Asked Questions

How many cards are in the Chinese CSM2cC set?

The Chinese CSM2cC set contains 37 cards in total.

What is the most valuable card in Chinese CSM2cC?

The most valuable card in the Chinese CSM2cC set is Gardevoir & Sylveon GX #167 at $268.50.

Is Chinese CSM2cC a good investment?

The Chinese CSM2cC set contains 37 cards with a current market value of $1753.90. Investment potential depends on individual card rarity, condition, and market demand. Consider researching specific high-value cards and market trends before making investment decisions.